Status:
COMPLETED
Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata
Lead Sponsor:
Services Institute of Medical Sciences, Pakistan
Conditions:
Extensive Alopecia Areata
Eligibility:
All Genders
18-60 years
Phase:
EARLY_PHASE1
Brief Summary
This clinical trial was conducted at the Dermatology department of Services hospital Lahore. Patients of extensive and treatment resistant Alopecia areata were enrolled after ethical approval and info...
Detailed Description
This clinical trial was conducted at the Dermatology department of Services hospital Lahore. Patients of extensive and treatment resistant Alopecia areata were enrolled after ethical approval and info...
Eligibility Criteria
Inclusion
- Either gender Age 18 to 60 years Extensive disease (SALT \> 24)
Exclusion
- Patients taking immunosuppressants or DMARDs Recent live vaccination Active or latent TB, Hepatitis B or C, HIV Malignancy Hypersensitivity to the drug Pregnant or lactating mothers
Key Trial Info
Start Date :
August 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 4 2023
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06157905
Start Date
August 6 2022
End Date
August 4 2023
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Services Institute of Medical Sciences
Lahore, Punjab Province, Pakistan, 54000